Boryung Pharmaceutical Co., Ltd.

Large South Korean pharma firms have reported mixed second-quarter earnings amid the ongoing medical care disruption in the country stemming from the prolonged standoff between the government and medi

South Korea’s Ministry of Food and Drug Safety (MFDS) issued approvals for the conduct of 783 clinical trials over the course of 2023, up 10.1% from the previous year, led by an increase in work in on

The South Korean pharma industry is beginning to feel the fallout from the prolonged national walkout by trainee doctors that began in February. Although the overall impact from the medical strike app

Korean pharma firms reported mixed earnings for the second quarter ended 30 June, with sales growth led by in-house new drugs, prescription businesses and the generally strong performances of overseas